ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ILDEFONSO RIVERA MD

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,753Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 194

$918K Total Retail Price of All Prescriptions

Rank: 9 out of 194

793 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 16,937 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $36 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,348 1,184 1 1
AMLODIPINE BESYLATE 916 732 2 2
METOPROLOL SUCCINATE 793 679 3 4
LOSARTAN POTASSIUM 700 530 4 3
GABAPENTIN 602 487 5 21
LOSARTAN-HYDROCHLOROTHIAZIDE 600 484 6 5
IRBESARTAN 523 450 10 7 31
SYNTHROID 453 382 8 17
PANTOPRAZOLE SODIUM 440 333 9 44
LEVOTHYROXINE SODIUM 425 384 10 20
CARVEDILOL 418 390 11 8
OMEPRAZOLE 410 323 12 23
LISINOPRIL 402 352 13 11
METFORMIN HCL ER 376 277 14 61
AMLODIPINE BESYLATE-BENAZEPRIL 361 271 15 30
DOXAZOSIN MESYLATE 343 284 16 19
DIOVAN 317 261 17 32
ATORVASTATIN CALCIUM 279 244 18 10
ISOSORBIDE MONONITRATE ER 268 251 19 12
TRAZODONE HCL 256 197 20 147
TRAMADOL HCL-ACETAMINOPHEN 243 158 21 54
NIFEDIPINE ER 240 185 22 47
INDAPAMIDE 237 178 23 48
DIGOXIN 220 177 24 26
SPIRONOLACTONE 219 189 25 37
QUINAPRIL HCL 200 156 26 58
SERTRALINE HCL 191 155 27 64
TORSEMIDE 190 152 28 110
GLYBURIDE-METFORMIN HCL 189 184 R 29 56
ZOLPIDEM TARTRATE 187 142 30 42
FOSINOPRIL SODIUM 187 159 30 71
CLOPIDOGREL 180 145 32 16
DIOVAN HCT 180 157 32 35
METFORMIN HCL 179 123 34 9
IRBESARTAN-HYDROCHLOROTHIAZIDE 174 141 10 35 65
AVAPRO 169 158 36 41
PLAVIX 166 126 37 18
NAMENDA 162 160 38 109
BISOPROLOL-HYDROCHLOROTHIAZIDE 155 130 39 49
GLIMEPIRIDE 153 123 40 29
SPIRONOLACTONE-HCTZ 152 110 41 130
HYDRALAZINE HCL 152 117 41 51
DONEPEZIL HCL 149 145 43 76
JANUMET 125 111 44 102
ALENDRONATE SODIUM 124 102 45 52
TERAZOSIN HCL 113 88 46 75
NIFEDICAL XL 108 88 47 101
GLIPIZIDE XL 106 88 48 90
GLIPIZIDE ER 104 76 49 87
VERAPAMIL ER 102 75 50 34
SINGULAIR 99 83 51 114
WARFARIN SODIUM 99 99 51 28
TRAMADOL HCL 98 91 53 95
LANTUS 95 73 54 74
CYMBALTA 92 62 55 174
HUMULIN 70-30 91 64 56 88
ATENOLOL-CHLORTHALIDONE 89 65 57 70
PAROXETINE HCL 87 81 58 116
DILTIAZEM ER 86 52 59 97
EVISTA 85 67 60 83
ALLOPURINOL 84 56 61 69
FENOFIBRATE 83 53 62 36
PRAVASTATIN SODIUM 82 75 63 25
TIZANIDINE HCL 82 48 63 179
ASPIRIN EC 81 71 65 24
RANITIDINE HCL 79 70 66 22
VYTORIN 74 72 67 53
JANUVIA 73 58 68 82
TAMSULOSIN HCL 73 68 68 62
INSULIN SYRINGE 72 54 70 125
FUROSEMIDE 68 37 71 14
FAMOTIDINE 67 43 72 55
GALANTAMINE HBR 62 62 73 167
LYRICA 61 41 74 141
MONTELUKAST SODIUM 61 51 74 160
HYDROCHLOROTHIAZIDE 57 44 76 13
ATENOLOL 57 52 76 7
COUMADIN 55 55 78 38
FINASTERIDE 53 53 79 128
RAMIPRIL 51 43 80 33
LANSOPRAZOLE 51 46 80 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.